Literature DB >> 2633924

Pharmacokinetics of atracurium besylate in the pig after a single i.v. injection.

C Schopfer1, J F Pittet, D R Morel, E Tassonyi, A Benakis.   

Abstract

A pharmacokinetic study of atracurium besylate was performed in the pig after a single i.v. bolus injection of 2 mg/kg, the dose needed to produce surgical neuromuscular blockade. The plasma concentration values were obtained by high performance liquid chromatography. Using a two-compartment pharmacokinetic model, the elimination half life was found to be 28.6 +/- 6.3 min (mean +/- SEM), the total volume of distribution 341 +/- 56 ml/kg and the plasma clearance 8.7 +/- 1.1 ml/min/kg. Although the doses required to obtain a satisfactory neuromuscular blockade as well as the plasma level, volume of distribution and plasma clearance values were higher in the pig than in man, the distribution and elimination half-lives were similar to those recently reported.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2633924     DOI: 10.1007/BF03190115

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  13 in total

Review 1.  Atracurium: an overview.

Authors:  R Hughes
Journal:  Br J Anaesth       Date:  1986       Impact factor: 9.166

2.  Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of orthotopic liver transplantation in pigs.

Authors:  J F Pittet; E Tassonyi; C Schopfer; D R Morel; G Mentha; M Fathi; C Le Coultre; D A Steinig; A Benakis
Journal:  Anesthesiology       Date:  1990-01       Impact factor: 7.892

3.  Simplified method for the determination of atracurium and laudanosine in pig plasma by high-performance liquid chromatography and fluorimetric detection.

Authors:  C Schopfer; A Benakis
Journal:  J Chromatogr       Date:  1990-03-16

4.  Comparative neuromuscular blocking effects of vecuronium, pancuronium, Org 6368 and suxamethonium in the anaesthetized domestic pig.

Authors:  A W Muir; R J Marshall
Journal:  Br J Anaesth       Date:  1987-05       Impact factor: 9.166

5.  Determination of atracurium besylate in human plasma.

Authors:  E A Neill; C R Jones
Journal:  J Chromatogr       Date:  1983-05-13

6.  In vitro degradation of atracurium in human plasma.

Authors:  R A Merrett; C W Thompson; F W Webb
Journal:  Br J Anaesth       Date:  1983-01       Impact factor: 9.166

7.  Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose).

Authors:  S Ward; E A Neill; B C Weatherley; I M Corall
Journal:  Br J Anaesth       Date:  1983-02       Impact factor: 9.166

8.  Atracurium: conception and inception.

Authors:  J B Stenlake; R D Waigh; J Urwin; G H Dewar; G G Coker
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

9.  Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.

Authors:  F F Foldes; A Deery
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

10.  Pharmacokinetics of atracurium and its metabolites.

Authors:  S Ward; B C Weatherley
Journal:  Br J Anaesth       Date:  1986       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.